Khaitan, TT&A, Hogan Lovells Act On Symbiotec Pharmalab’s Proposed IPO Pharmaceuticals December 27, 2025 Capital Markets – Equity
JSA, CMS INDUSLAW Advised On Zota Health Care’s ₹350 Cr QIP Pharmaceuticals December 25, 2025 Capital Markets
SAM, JSA Advised On CORONA Remedies’ ₹655 Cr IPO Pharmaceuticals December 25, 2025 Capital Markets – Equity
SAM, CAM Act On Eris Lifesciences’ Acquisition Of Stake In Swiss Parenterals Pharmaceuticals December 10, 2025 Mergers & Acquisitions
JSA, TT&A, Veritas, AZB Act On Acquisition Of Shares Of La Renon Healthcare By Investor Consortium Pharmaceuticals December 8, 2025 Private Equity
CAM, S&R, Hogan Lovells Act On Sudeep Pharma’s IPO Pharmaceuticals December 1, 2025 Capital Markets – Equity
White & Case, JSA, Freshfields, Kirkland & Ellis Advised On GTCR’s €4.1 Bn Acquisition Of Zentiva Pharmaceuticals September 15, 2025 Mergers & Acquisitions
Desai & Diwanji Advised Ceph Lifesciences On Acquisition Of Nectar Lifesciences’ API Business Pharmaceuticals July 18, 2025 Mergers & Acquisitions
AZB Advised JB Pharma’s Board On Acquisition Of Stake By Torrent Pharma Pharmaceuticals July 7, 2025 Mergers & Acquisitions
JSA Advised On Suven Pharma’s Merger With Cohance Lifesciences Pharmaceuticals May 15, 2025 Mergers & Acquisitions
